BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.063x

Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs149.66 Million ≈ $1.62 Million USD) by net assets (Rs2.38 Billion ≈ $25.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BALAXI PHARMACEUTICALS LIMITED (BALAXI) liquidity interval to measure how many days the company can operate on defensive assets alone.

BALAXI PHARMACEUTICALS LIMITED - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BALAXI PHARMACEUTICALS LIMITED Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Intrusion Inc NASDAQ:INTZ	-0.492x
K Wave Media Ltd. NASDAQ:KWM	-166.159x
Wanted Lab Inc. KQ:376980	0.017x
NSX Ltd AU:NSX	0.587x
NetX Holdings Bhd KLSE:0020	0.025x
Klimator AB ST:KLIMAT	0.368x
MSCM Holdings Bhd KLSE:0041	-0.048x
Euromedis Groupe SA PA:ALEMG	0.048x

Annual Cash Flow Conversion Efficiency for BALAXI PHARMACEUTICALS LIMITED (2013–2025)

The table below shows the annual cash flow conversion efficiency of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see BALAXI market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.32 Billion ≈ $25.06 Million	Rs-377.82 Million ≈ $-4.09 Million	-0.163x	-774.66%
2024-03-31	Rs2.01 Billion ≈ $21.78 Million	Rs48.66 Million ≈ $526.25K	0.024x	-27.26%
2023-03-31	Rs1.83 Billion ≈ $19.78 Million	Rs60.75 Million ≈ $657.02K	0.033x	-88.99%
2022-03-31	Rs1.13 Billion ≈ $12.24 Million	Rs341.44 Million ≈ $3.69 Million	0.302x	+632353.73%
2021-03-31	Rs649.80 Million ≈ $7.03 Million	Rs31.00K ≈ $335.25	0.000x	+100.01%
2020-03-31	Rs277.46 Million ≈ $3.00 Million	Rs-140.62 Million ≈ $-1.52 Million	-0.507x	-18.39%
2019-03-31	Rs35.21 Million ≈ $380.73K	Rs-15.07 Million ≈ $-162.98K	-0.428x	+1.89%
2018-03-31	Rs15.55 Million ≈ $168.13K	Rs-6.78 Million ≈ $-73.35K	-0.436x	-3.84%
2017-03-31	Rs23.59 Million ≈ $255.13K	Rs-9.91 Million ≈ $-107.20K	-0.420x	+88.57%
2016-03-31	Rs314.87K ≈ $3.41K	Rs-1.16 Million ≈ $-12.52K	-3.676x	-156.12%
2015-03-31	Rs322.45K ≈ $3.49K	Rs2.11 Million ≈ $22.84K	6.551x	+2233.63%
2014-03-31	Rs7.80 Million ≈ $84.33K	Rs-2.39 Million ≈ $-25.89K	-0.307x	-171.16%
2013-03-31	Rs7.52 Million ≈ $81.34K	Rs3.25 Million ≈ $35.09K	0.431x	--

About BALAXI PHARMACEUTICALS LIMITED

NSE:BALAXI India Drug Manufacturers - Specialty & Generic

Market Cap

$14.13 Million

Rs1.31 Billion INR

Market Cap Rank

#26169 Global

#1455 in India

Share Price

Rs23.67

Change (1 day)

+0.47%

52-Week Range

Rs15.67 - Rs50.27

All Time High

Rs207.74